ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
NDDRF 2.0: An update and expansion of risk factor knowledge base for personalized prevention of neurodegenerative diseases.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Benchmarking Large Language Models and Prompt Engineering Strategies in Microsatellite Instability Cancers: Evaluation Study.Journal of medical Internet research · 2026Article
- MSICKB: A Curated Knowledgebase for Exploring Molecular Heterogeneity and Biomarker Prioritization in Microsatellite Instability Cancers.Computational and structural biotechnology journal · 2026Article
- NDDRF 2.0: An update and expansion of risk factor knowledge base for personalized prevention of neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionNeurodegenerative diseases (NDDs) are chronic diseases caused by brain neuron degeneration, requiring systematic integration of risk factors to address their heterogeneity. Established in 2021, Knowledgebase of Risk Factors for Neurodegenerative Diseases (NDDRF) was the first knowledge base to consolidate NDD risk factors. NDDRF 2.0 expands focus to modifiable lifestyle-related factors, enhancing utility for NDD prevention.
methodsData from the past 4 years were comprehensively updated, while lifestyle factors were manually collected and filtered from 1975 to 2024. Each factor was embedded with International Classification of Diseases codes and clinical stage annotations, and then re-standardized, classified, and annotated in accordance with the Unified Medical Language System Semantic Network.
resultsNDDRF 2.0 encompasses 1971 risk factors classified under 151 subcategories across 20 NDDs, including 536 lifestyle-related factors covering six major categories and is freely accessible at http://sysbio.org.cn/NDDRF/. DISCUSSION: As the first lifestyle-specific and holistic knowledge base for NDDs, NDDRF 2.0 offers structured and deep phenotype information, enabling personalized prevention strategies and clinical decision support. HIGHLIGHTS: An enhanced lifestyle-specific and holistic knowledge base (Knowledgebase of Risk Factors for Neurodegenerative Diseases [NDDRF] 2.0) was built for neurodegenerative diseases (NDDs). NDDRF 2.0 provides detailed categorization and deep phenotypes to support targeted NDD prevention. NDDRF 2.0 provides a knowledge-driven resource that facilitates personalized risk assessment and proactive health management. NDDRF 2.0 provides clinicians, researchers, and at-risk populations with knowledge to develop and implement effective risk prevention strategies. NDDRF 2.0 can be used to build chatbots by enhancing large language models in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.